Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy

被引:9
|
作者
Wang, Bin [1 ]
Hu, Jing [1 ]
Zhang, Jian [2 ]
Zhao, Lina [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, 15 West Changle Rd, Xian 710032, Peoples R China
[2] Air Force Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China
关键词
Radiotherapy; TCF-1; Stem CD8+T; cGAS; STING; TME; CD8(+) T-CELLS; RADIOTHERAPY; MICROENVIRONMENT; IMMUNITY; TRIAL;
D O I
10.1016/j.intimp.2022.108646
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific immunity, and recent investigations demonstrate that the efficiency of local high-dose radiotherapy is attributable to the presence of CD8+T cells. Here, we observed that high-dose radiation remarkably increased the enrichment of stem cell-like CD8+T cells. Moreover, cGAS/STING signaling augmented stem cell-like CD8+T cells and T stem-like central memory CD8+T cells in a mice tumor model after radiation. These findings raise our understanding of stem celllike CD8+T cells after radiation stimulation and improve radiation therapy by driving the cGAS/STING signaling pathway for cancer multimodality therapy.
引用
收藏
页数:6
相关论文
共 46 条
  • [21] Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites
    Alexandra L. Martin
    Chase Powell
    Mate Z. Nagy
    Patrick Innamarato
    John Powers
    Derek Nichols
    Carmen M. Anadon
    Ricardo A. Chaurio
    Sungjune Kim
    Min-hsuan Wang
    Bing Gong
    Xianzhe Wang
    Thomas J. Scheutz
    Scott J. Antonia
    Jose R. Conejo-Garcia
    Bradford A. Perez
    Cancer Immunology, Immunotherapy, 2023, 72 : 1445 - 1460
  • [22] Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites
    Martin, Alexandra L.
    Powell, Chase
    Nagy, Mate Z.
    Innamarato, Patrick
    Powers, John
    Nichols, Derek
    Anadon, Carmen M.
    Chaurio, Ricardo A.
    Kim, Sungjune
    Wang, Min-hsuan
    Gong, Bing
    Wang, Xianzhe
    Scheutz, Thomas J.
    Antonia, Scott J.
    Conejo-Garcia, Jose R.
    Perez, Bradford A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1445 - 1460
  • [23] Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
    Kang, Tae Heung
    Mao, Chih-Ping
    He, Liangmei
    Tsai, Ya-Chea
    Liu, Katherine
    La, Victor
    Wu, T. -C.
    Hung, Chien-Fu
    PLOS ONE, 2012, 7 (04):
  • [24] Circulating tumor cells counts are associated with CD8+T cell levels in programmed death-ligand 1-negative non-small cell lung cancer patients after radiotherapy A retrospective study
    Liu, Qingyun
    Zhao, Chaoren
    Jiang, Penghui
    Liu, Dawei
    MEDICINE, 2021, 100 (29)
  • [25] A distinct stimulatory cDC1 subpopulation amplifies CD8+T cell responses in tumors for protective anti-cancer immunity
    Meiser, Philippa
    Knolle, Moritz A.
    Hirschberger, Anna
    de Almeida, Gustavo P.
    Bayerl, Felix
    Lacher, Sebastian
    Pedde, Anna-Marie
    Flommersfeld, Sophie
    Hoenninger, Julian
    Stark, Leonhard
    Stoegbauer, Fabian
    Anton, Martina
    Wirth, Markus
    Wohlleber, Dirk
    Steiger, Katja
    Buchholz, Veit R.
    Wollenberg, Barbara
    Zielinski, Christina E.
    Braren, Rickmer
    Rueckert, Daniel
    Knolle, Percy A.
    Kaissis, Georgios
    Boettcher, Jan P.
    CANCER CELL, 2023, 41 (08) : 1498 - +
  • [26] Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
    MacNabb, Brendan W.
    Tumuluru, Sravya
    Chen, Xiufen
    Godfrey, James
    Kasal, Darshan N.
    Yu, Jovian
    Jongsma, Marlieke L. M.
    Spaapen, Robbert M.
    Kline, Douglas E.
    Kline, Justin
    IMMUNITY, 2022, 55 (06) : 982 - +
  • [27] Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
    Zhu, Xinhai
    Li, Ke
    Liu, Guichao
    Wu, Ruan
    Zhang, Yan
    Wang, Siying
    Xu, Meng
    Lu, Ligong
    Li, Peng
    GUT MICROBES, 2023, 15 (02)
  • [28] The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies
    Jensen, Benjamin A. H.
    Pedersen, Sara R.
    Christensen, Jan P.
    Thomsen, Allan R.
    PLOS ONE, 2013, 8 (06):
  • [29] Lymph node and tumor-associated PD-L1+macrophages antagonize dendritic cell vaccines by suppressing CD8+T cells
    Sprooten, Jenny
    Vanmeerbeek, Isaure
    Datsi, Angeliki
    Govaerts, Jannes
    Naulaerts, Stefan
    Laureano, Raquel S.
    Borras, Daniel M.
    Calvet, Anna
    Malviya, Vanshika
    Kuballa, Marc
    Felsberg, Jorg
    Sabel, Michael C.
    Rapp, Marion
    Knobbe-Thomsen, Christiane
    Liu, Peng
    Zhao, Liwei
    Kepp, Oliver
    Boon, Louis
    Tejpar, Sabine
    Borst, Jannie
    Kroemer, Guido
    Schlenner, Susan
    De Vleeschouwer, Steven
    Sorg, Ruediger V.
    Garg, Abhishek D.
    CELL REPORTS MEDICINE, 2024, 5 (01)
  • [30] Delivery of IL2RG mRNA via nanoparticles to enhance CD8+ T cell promotes anti-tumor effects against late-stage triple-negative breast cancer
    Li, Ying
    Huang, Fang
    Deng, Ruoying
    Jiang, Da
    CANCER NANOTECHNOLOGY, 2024, 15 (01)